Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy
2018 · JNCI Journal of the National Cancer Institute · 89 citations
https://doi.org/10.1093/jnci/djy076
Y
Yacine Barèche
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
2.3K
Citations
19
h-index
24
i10-index
Yacine Barèche is an academic researcher. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Immunotherapy and Biomarkers & Advanced Breast Cancer Therapies. The author has an h-index of 19, co-authored 95 publications.
ORCID: 0000-0002-7208-6494Papers by this author
worksMicroRNA profiling and identification of let-7a as a target to prevent chemotherapy-induced primordial follicles apoptosis in mouse ovaries
2019 · Scientific Reports · 40 citations
https://doi.org/10.1038/s41598-019-45642-w
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma
2023 · Cell Reports Medicine · 26 citations
https://doi.org/10.1016/j.xcrm.2023.101188
Genomic, Transcriptomic, Epigenetic, and Immune Profiling of Mucinous Breast Cancer
2019 · JNCI Journal of the National Cancer Institute · 23 citations
https://doi.org/10.1093/jnci/djz023
The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
2017 · npj Breast Cancer · 14 citations
https://doi.org/10.1038/s41523-017-0026-6
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
2023 · Med · 14 citations
https://doi.org/10.1016/j.medj.2023.07.006
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat